NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy

Clinical Trial ID NCT02319824

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial Watch: Adoptive cell transfer for oncological indications.	Oncoimmunology	2015	0.84
2	Trial Watch: Immunotherapy plus radiation therapy for oncological indications.	Oncoimmunology	2016	0.81